CD94/NKG2 Inhibitory Receptor Complex Modulates Both Anti-Viral and Anti-Tumoral Responses of Polyclonal Phosphoantigen-Reactive Vγ9Vδ2 T Lymphocytes

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 6009-6017

  Poccia, Fabrizio ^a   Cipriani, Barbara ^a   Vendetti, Silvia ^a   Colizzi, Vittorio ^a   Poquet, Yannick ^c   Battistini, Luca ^b   López Botet, Miguel ^d   Fournié, Jean Jacques ^c   Gougeon, Marie Lise ^e  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Ist Ric Cura Carattere Sci S L   (Italy)

^c CHU PURPAN   (France)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD94 ANTIGEN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; KLRD1 PROTEIN, HUMAN; LECTIN; LECTIN RECEPTOR; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; NATURAL KILLER CELL ACTIVATING RECEPTORS; VIRUS ANTIGEN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; GENE REARRANGEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGLOBULIN GENE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MYCOBACTERIUM FORTUITUM; NATURAL KILLER CELL; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, CD94; ANTIGENS, VIRAL; CYTOTOXICITY TESTS, IMMUNOLOGIC; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; GENES, IMMUNOGLOBULIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV-1; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MYCOBACTERIUM FORTUITUM; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, IMMUNOLOGIC; RECEPTORS, MITOGEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0031573616     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Lanier, L. L., and J. H. Phillips. 1996. Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today 17:86.
2. Moretta, A., C. Bottino, M. Vitale, D. Pende, R. Biassoni, M. C. Mingari, and L. Moretta. 1996. Receptors for HLA class I molecules in human natural killer cells. Annu. Rev. Immunol. 14:619.
3. Wagtmann, N. R., C. Biassoni, S. Verdiani, M. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, and E. O. Long. 1995. Molecular clones of the p58 natural killer cell receptor reveal lg-related molecules with diversity in both extra- and intracellular domains. Immunity 2:439.
4. Colonna, M., and J. Samaridis. 1995. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition of human natural killer cells. Science 268:405.
5. Carretero, M., C. Cantoni, T. Bellon, C. Bottino, R. Biassoni, A. Rodriguez, J. J. Pérez-Villar, L. Moretta, A. Moretta, and M. López-Botet. 1997. The CD94 and NKG2-A C-type lectins covalently assemble to form an NK cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 27:563.
6. Yokoyama, W. M. 1995. Natural killer cell receptors. Curr. Opin. Immunol. 7:110.
7. Ljunggren, H. G., and K. Karre. 1990. In search of the missing self: MHC molecules and NK cell recognition. Immunol. Today 11:237.
8. Campbell, K. S., M. Dessing, M. López-Botet, M. Cella, and M. Colonna. 1996. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. Exp. Med. 184:93.
9. Fry, A., L. L. Lanier, and A. Weiss. 1996. Phosphotyrosines in the KIR motif of NKB1 are required for negative signaling and for association with PTP1C. J. Exp. Med. 184:295.
10. Olcese, L. P., P. Lang, F. Vely, A. Cambiaggi, D. Marguet, M. Blery, K. L. Hippen, R. Biassoni, A. Moretta, L. Moretta, J. C. Cambier, and E. Vivier. 1996. Human and mouse killer-cell inhibitory receptors recruit PTP1-C and PTP1-D protein tyrosine phosphatases. J. Immunol. 156:4331.
11. López-Botet, M., J. J. Pérez-Villar, M. Carretero, A. Rodriguez, I. Melero, T. Bellón, M. Llano, and F. Navarro. 1997. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol. Rev. 155:165.
12. Lazetic, S., C. Chang, J. P. Houchins, L. L. Lanier, and J. H. Phillips. 1996. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157: 4741.
13. + T lymphocytes subsets that express HLA-class I specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA 93:12433.
14. Lanier, L. L., J. Ruitenberg, R. L. Bolhuis, J. Borst, J. H. Phillips, and R. Testi. 1988. Structural and serological heterogeneity of γ/δ T cell antigen receptor expression in thymus and peripheral blood. Eur. J. Immunol. 18:1985.
15. Groh, V., S. Porcelli, M. Fabbi, L. L. Lanier, L. J. Picker, T. Anderson, R. A. Warnke, A. K. Bhan, J. L. Strominger, and M. B. Brenner. 1989. Human lymphocytes bearing T cell receptor γ/δ are phenotypically diverse and evenly distributed throughout the lymphoid system. J. Exp. Med. 169:1277.
16. Parker, C. M., V. Groh, H. Band, S. A. Porcelli, C. Morita, M. Fabbi, D. Glass, J. L. Strominger, and M. B. Brenner. 1990. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J. Exp. Med. 171:1597.
17. Brenner, M. B., J. McLean, H. Scheft, J. Riberdy, S. L. Ang, J. G. Seidman, P. Devlin, and M. S. Krangel. 1987. Two forms of the T-cell receptor gamma protein found on peripheral blood cytotoxic T lymphocytes. Nature 325:689.
18. Constant, P., F. Davodeau, M. A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J. J. Fournie. 1994. Stimulation of γδ T cells by nonpeptidic mycobacterial ligands. Science 264:267.
19. Tanaka, I., C. T. Morita, Y. Tanaka, E. Nieves, M. B. Brenner, and B. R. Bloom. 1995. Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 375:155.
20. Burk, M. R., L. Mori, and G. De Libero. 1995. Human Vγ9-Vδ2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur. J. Immunol. 25:2052.
21. Bukowski, J. F., C. T. Morita, Y. Tanaka, B. R. Bloom, M. B. Brenner, and H. Band. 1995. Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 154:998.
22. Fisch, P., M. Malkovsky, S. Kovats, E. Strum, E. Braakman, B. S. Klein, S. D. Voss, L. W. Morrissey, R. DeMars, W. J. Welch, R. L. H. Bolhuis, and P. M. Sondel. 1990. Recognition by human Vγ9/Vδ2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 250:1269.
23. Fisch, P., K. Oettel, N. Fudim, J. E. Surfus, M. Malkovsky, and P. M. Sondel. 1992. MHC-unrestricted cytotoxic and proliferative responses of two distinct human γδ T cell subsets to Daudi cells. J. Immunol. 148:2315.
24. + lymphokine-activated killer cells against K562 and Daudi cells. Cancer Immunol. Immunother. 36:331.
25. Malkovsky, M., S. R. Bartz, D. Mackenzie, B. E., M. Wallace, J. Manning, C. D. Pauza, and P. Fish. 1992. Are γδ T cells important for the elimination of virus-infected cells? J. Med. Primatol. 21:113.
26. Malkovsky, M. 1992. The function and specificity of γδ T cells. Vaccine Res. 1:183.
27. + human cytotoxic T lymphocytes. J. Immunol. 150:1437.
28. Wallace, M., Y. H. Gan, C. D. Pauza, and M. Malkovsky. 1994. Antiviral activity of primate γδ T lymphocytes isolated by magnetic cell sorting. J. Med. Primatol. 23:131.
29. Bukowski, J. F., C. T. Morita, and M. B. Brenner. 1994. Recognition and destruction of virus-infected cells by human γδ CTL. J. Immunol. 153:5134.
30. Wallace, M., S. R. Bartz, W. L. Chang, D. A. Mackenzie, C. D. Pauza, and M. Malkovsky. 1996. γδ T lymphocyte responses to HIV. Clin. Exp. Immunol. 103:107.
31. Nakajiama, H., H. Tomiyama, and M. Takiguchi. 1995. Inhibition of γδ T cell recognition by receptors for MHC class I molecules. J. Immunol. 155:4139.
32. Rubio, G., J. Aramburu, J. Ontanòn, M. López-Botet, and P. Aparicio. 1993. A novel functional cell surface dimer (Kp43) serves as accessory molecule for the activation of a subset of human γδ T cells. J. Immunol. 151:1312.
33. Mingari, M. C., C. Vitale, A. Cambiaggi, F. Schiavetti, G. Melioli, S. Ferrini, and A. Poggi. 1995. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int. Immunol. 7:697.
34. Poccia, F., S. Boullier, H. Lecoeur, M. Cochet, Y. Poquet, V. Colizzi, J. J. Foumier, and M. L. Gougeon. 1996. Peripheral Vγ9/Vδ2 T cell deletion and anergy to non-peptidic mycobacterial antigens in asymptomatic HIV-1 infected persons. J. Immunol. 157:4449.
35. + T lymphocytes. Modulation of natural killer cytotoxicity by anti Kp43 monoclonal antibody. J. Immunol. 147:714.
36. Sivori, S., M. Vitale, C. Bottino, E. Marcenato, L. Sanseverino, S. Parolini, L. Moretta, and A. Moretta. 1996. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 26:2487.
37. Ferrini, S., A. Cambiaggi, R. Meazza, S. Sforzini, S. Marciano, M. C. Mingari, and L. Moretta. 1994. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 24:2294.
38. Melero, I., A. Salmerón, M. A. Balboa, J. Aramburu, and M. López-Botet. 1994. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J. Immunol. 152:1662.
39. Döhring, C., D. Scheidegger, J. Samaridis, M. Cella, and M. Colonna. 1996. A human killer inhibitory receptor specific for HLA-A. J. Immunol. 156:3098.
40. Poquet, Y., P. Constant, M. A. Peyrat, R. Poupot, F. Halary, M. Bonneville, and J. J. Fournié. 1996. High-pH anion-exchange chromatographic analysis of phosphorylated compounds: application to isolation and characterization of nonpeptidic mycobacterial antigens. Anal. Biochem. 243:119.
41. Jung, T., U. Schauer, C. Heusser, C. Neumann, and C. Rieger. 1993. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 159:197.
42. Di Cesare, S., F. Poccia, A. Mastino, and V. Colizzi. 1992. Surface expressed heat shock proteins by stressed or human immunodeficiency virus (HIV)-infected lymphoid cells represent the target for antibody-dependent cellular cytotoxicity. Immunology 76:341.
43. Sells, M. A., M. L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84:1005.
44. Moretta, A., M. Vitale, S. Sivori, C. Bottino, L. Morelli, R. Augugliaro, M. Barbesi, D. Pende, E. Ciccone, M. López-Botet, and L. Moretta. 1994. Human natural killer cell receptors for HLA-class I molecules: evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J. Exp. Med. 180:545.
45. Phillips, J. H., C. Chang, J. Mattson, J. E. Gumperz, P. Parham, and L. Lanier. 1996. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, -B, and -C allotypes. Immunity 5:163.
46. Pérez-Villar, J. J., I. Melero, F. Navarro, M. Carretero, T. Bellón, M. Llano, M. Colonna, D. E. Geraghty, and M. López-Botet. 1997. The CD94/NKG2-A inhibitory receptor complex is involved in NK cell-mediated recognition of cells expressing HLA-G1. J. Immunol. 158:5736.
47. Jiang, Y. Z., D. Couriel, D. A. Mavroudis, P. Lewalle, V. Malkovska, N. F. Hensel, S. Dermine, J. Molldrem, and A. J. Barret. 1996. Interaction of natural killer cells with MHC class II: reversal of HLA-DR1-mediated protection of K562 transfectants from natural killer cell-mediated cytolysis by brefeldin-A. Immunology 87:481.
48. Browning, M. J., J. A. Madrigal, P. Krausa, H. Kowalski, C. E. Allsopp, A. M. Little, S. Turner, E. J. Adams, K. L. Arnett, W. F. Bodmer, J. G. Bodmer, and P. Parham. 1995. The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and HLA-B alleles. Tissue Antigens 45:177.
49. Kaufmann, S. H. E. 1996. γ/δ and other unconventional T lymphocytes: what do they see and what do they do? Proc. Natl. Acad. Sci. USA 93:2272.
50. Modlin, R. L., C. Pirmez, F. M. Hofman, V. Torigian, K. Uyemura, T. H. Rea, B. R. Bloom, and M. B. Brenner. 1989. Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature 339:544.
51. Ho, M., H. K. Webster, P. Tongtawe, K. Pattanapanyasat, and W. P. Weidanz. 1990. Increased γδ cells in acute Plasmodium falciparum malaria. Immunol. Lett. 25:139.
52. Ohga, S., Y. Yoshikai, Y. Y. Takeda, K. Hiromatsu, and K. Nomoto. 1990. Sequential appearance of γ/δ and α/β-bearing T cells in the peritoneal cavity during an i.p. infection with Listeria monocytogenes. Eur. J. Immunol. 20:533.
53. Kabelitz, D., A. Bender, T. Prospero, S. Wesselborg, O. Janssen, and K. Pechold. 1991. The primary response of human γδ T cells to Mycobacterium tuberculosis is restricted to Vγ9-bearing cells. J. Exp. Med. 173:1331.
54. Constant, P., Y. Poquet, M. A. Peyrat, F. Davodeau, M. Bonneville, and J. J. Fournié. 1995. The antituberculous Mycobacterium bovis BCG vaccine is an attenuated mycobacterial producer of phosphorylated non peptidic antigens for human γδ T cells. Infect. Immun. 63:4628.
55. Behr, C., R. Poupot, M. A. Peyrat, Y. Poquet, P. Constant, P. Dubois, M. Bonneville, and J. J. Fournié. 1996. Plasmodium falciparum stimuli for human γδ T cells are related to phosphorylated antigens of mycobacteria. Infect. Immun. 64:2892.
56. Poquet, Y., F. Halary, E. Champagne, F. Davodeau, M. L. Gougeon, M. Bonneville, and J. J. Fournié. 1997. Human γδ T cells in tuberculosis. Res. Immunol. 147:542.
57. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J. P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4:77.
58. Renard, V., A. Cambiaggi, F. Vély, M. Bléry, L. Olcese, S. Olivero, M. Bouchet, and E. Vivier. 1997. Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immun. Rev. 155:205.
59. Plas, D. R., R. Johnson, J. T. Pingel, R. J. Matthews, M. Dalton, G. Roy, A. C. Chan, and M. L. Thomas. 1996. Direct regulation of ZAP-70 by SHP-1 in T-cell receptor antigen signaling. Science 272:1173.
60. Janeway, C. A., Jr. 1992. The T cell receptor as a multi-component signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10:645.
61. Thomas, M. L. 1995. Of ITAMs and ITIMs. Turning on and off the B cell antigen receptor. J. Exp. Med. 181:1953.
62. Penninger, J. M., T. Wen, E. Timms, J. Potter, V. A. Wallace, T. Matsuyama, D. Ferrick, B. Sydora, M. Kronenberg, and T. W. Mak. 1995. Spontaneous resistance to acute T-cell leukemias in TCR Vγ1.1Jγ4Cγ4 transgenic mice. Nature 375:241.
63. Malkovska, V., F. Cigel, and B. E. Storer. 1994. Human T cells in hu-PBL-SCID mice proliferate in response to Daudi lymphoma and confer anti-tumour immunity. Clin. Exp. Immunol. 96:158.
64. Muller, D., P. Pakpreo, J. Filla, K. Pederson, F. Cigel, and V. Malkovska. 1995. Increased gamma-delta-T lymphocytes responses to Mycobacterium bovis BCG in major histocompatibility complex class I-deficient mice. Infect. Immun. 63: 2361.
65. Ahn, K., A. Angulo, P. Ghazal, P. A. Peterson, Y. Yand, and K. Fruh. 1996. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA 93:10990.
66. Reyburn, H. T., O. Mandelboim, M. Valés-Gomez, D. M. Davis, L. Pazmany, and J. L. Strominger. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514.
67. Howcroft, T. K., K. Strebel, M. A. Martin, and D. S. Singer. 1993. Repression of MHC class I promoter activity by two-exon tat of HIV. Science 260:320.
68. Schwartz, O., V. Marechal, S. Le Gall, F. Lemonnier, and J. M. Heard. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:338.
69. Carbone, E., G. Terrazzano, M. Colonna, L. Tuosto, E. Piccolella, L. Franksson, G. Palazzolo, J. J. Pérez-Villar, S. Fontana, K. Karre, and S. Zappacosta. 1996. Natural killer clones recognize specific soluble HLA class I molecules. Eur. J. Immunol. 26:683.
70. Puppo, F., S. Brenci, L. Lanza, O. Bosco, M. A. Imro, M. Scudeletti, F. Indiveri, and S. Ferrone. 1994. Increased level of serum HLA class I antigens in HIV infection: correlation with disease progression. Hum. Immunol. 40:259.
71. Wallace, M., A. M. Scharko, C. D. Pauza, P. Fish, K. Imaoka, S. Kawabata, K. Fujihashi, H. Kiyono, Y. Tanaka, B. R. Bloom, and M. Malkovsky. 1997. Functional γδ T cell defect associated with human immunodeficiency virus infection. Mol. Med. 3:60.
72. Poccia, F., M. Malkovsky, M. L. Gougeon, M. Bonneville, M. Lopez-Botet, J. J. Fournie, and V. Colizzi. 1997. γδ T cell activation or anergy during infections: the role of nonpeptidic TCR ligands and HLA class I molecules. J. Leukocyte Biol. 62:1.